Table 3 Hazard ratios (HRs) and 95% confidence intervals (CI) for breast cancer specific and overall mortality per THRα-2 expression
Endpoint | THRα-2 | All (n) | Deaths (n) | HRcrude (95% CI) | HRa (95% CI) | HRb (95% CI) | HRCC (95% CI) |
|---|---|---|---|---|---|---|---|
Breast cancer specific mortality | Low | 309 | 67 | 1.38 (0.96–1.99) | 1.48 (1.03–2.14) | 0.98 (0.66–1.45) | 0.81 (0.52–1.26) |
All of follow-up | High | 345 | 52 | 1 | 1 | 1 | 1 |
Total | 654 | 119 | |||||
Breast cancer specific mortality | Low | 309 | 61 | 1.52 (1.03–2.24) | 1.64 (1.11–2.43) | 1.04 (0.68–1.58) | 0.86 (0.54–1.39) |
0–15 years of follow-up | High | 345 | 44 | 1 | 1 | 1 | 1 |
Total | 654 | 105 | |||||
Overall mortality | Low | 309 | 127 | 1.04 (0.82–1.34) | 1.22 (0.95–1.56) | 0.94 (0.72–1.23) | 0.89 (0.65–1.21) |
All of follow-up | High | 345 | 127 | 1 | 1 | 1 | 1 |
Total | 654 | 254 | |||||
Overall mortality | Low | 309 | 110 | 1.16 (0.82–1.34) | 1.36 (1.04–1.79) | 1.00 (0.75–1.34) | 0.94 (0.68–1.32) |
0–15 years of follow-up | High | 345 | 102 | 1 | 1 | 1 | 1 |
Total | 654 | 212 |